Sana Biotechnology
SANA
SANA
147 hedge funds and large institutions have $810M invested in Sana Biotechnology in 2024 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 58 increasing their positions, 36 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
less funds holding
Funds holding: →
19% less call options, than puts
Call options by funds: $6.73M | Put options by funds: $8.35M
22% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 27
45% less capital invested
Capital invested by funds: $1.46B → $810M (-$653M)
Holders
147
Holding in Top 10
4
Calls
$6.73M
Puts
$8.35M
Top Buyers
| 1 | +$28M | |
| 2 | +$10.9M | |
| 3 | +$3.95M | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
+$3.37M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.59M |
Top Sellers
| 1 | -$17.7M | |
| 2 | -$9.98M | |
| 3 | -$9.84M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$3.73M |
| 5 |
OCA
Octagon Capital Advisors
New York
|
-$3.61M |